Home › Funds › PARADIGM CAPITAL MANAGEMENT INC/NY › GMED

PARADIGM CAPITAL MANAGEMENT INC/NY position in GMED

GLOBUS MED INC · Health Care

PARADIGM CAPITAL MANAGEMENT INC/NY reported holding 935,499 shares of GMED (GLOBUS MED INC) in its Q3 2026 13F filing — a position valued at US$70.1M, representing 2.21% of its reported portfolio and ranking #12 among its reported holdings. PARADIGM CAPITAL MANAGEMENT INC/NY has disclosed GMED holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)935.50K sh
Reported value held$70.07M
Portfolio Weight2.21%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How PARADIGM CAPITAL MANAGEMENT INC/NY's GMED position evolved

PARADIGM CAPITAL MANAGEMENT INC/NY first disclosed a stake in GMED in Q3 2023 at 984,100 shares (US$48.9M). The position peaked in Q4 2025 at 945,799 shares, worth US$82.6M. Across 13 filings, PARADIGM CAPITAL MANAGEMENT INC/NY increased the stake 4 time(s), trimmed it 5 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 935,499 shares valued at US$70.1M — an increase of 49,000 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 984.10K $48.86M New
Q4 2023 991.80K $52.85M Add
Q1 2024 1.01M $54.25M Add
Q2 2024 1.00M $68.59M Reduce
Q3 2024 971.40K $69.49M Reduce
Q4 2024 949.30K $78.52M Reduce
Q1 2025 949.30K $69.49M Hold
Q2 2025 942.30K $55.61M Reduce
Q3 2025 946.80K $54.22M Hold
Q4 2025 945.80K $82.58M Hold
Q1 2026 822.30K $70.85M Reduce
Q2 2026 886.50K $70.04M Add
Q3 2026 935.50K $70.07M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GMED and 13F data

GMED (GLOBUS MED INC) is a Health Care company. 36 other funds we track also report a position in GMED — the largest reported positions include KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (US$338.1M), Sculptor Capital LP (US$237.0M), Boston Trust Walden Corp (US$123.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GMED

All GMED fund holders →

FAQ

How long has PARADIGM CAPITAL MANAGEMENT INC/NY held GMED?

PARADIGM CAPITAL MANAGEMENT INC/NY has disclosed GMED holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is PARADIGM CAPITAL MANAGEMENT INC/NY's current position in GMED?

As of Q3 2026, PARADIGM CAPITAL MANAGEMENT INC/NY holds 935.50K shares of GMED (GLOBUS MED INC), valued at $70.07M, representing 2.21% of its reported portfolio and ranking #12.

Has PARADIGM CAPITAL MANAGEMENT INC/NY been buying or selling GMED?

In the latest 13F filing (Q3 2026), PARADIGM CAPITAL MANAGEMENT INC/NY increased its position in GMED. The position peaked in Q4 2025 at 945.80K shares.

Which other funds hold GMED?

Other major institutional holders of GMED include KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, Sculptor Capital LP, Boston Trust Walden Corp, among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.